We are live on ! Find out more
DSCI

Derma Sciences
DSCI

Delisted

DSCI was delisted on the 23rd of February, 2017.

62 hedge funds and large institutions have $174M invested in Derma Sciences in 2015 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 19

1.71% less ownership

Funds ownership: 83.87% → 82.16% (-1.7%)

6% less funds holding

Funds holding: 66 → 62 (-4)

14% less capital inflows, than outflows

Capital inflows: $25.7M | Capital outflows: $29.9M

22% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 18

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $15K

Holders
62
Holders Change
-4
Holders Change %
-6.06%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
14
Increased
24
Reduced
19
Closed
18
Calls
–
Puts
$15K
Net Calls
-$15K
Net Calls Change
+$217K

DSCI Hedge Fund Activity: Q2 2015 in Review

62 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences (DSCI) for Q2 2015, worth a combined $174M — down 4.5% from $183M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of DSCI and 14 opened new positions — a net loss of 4 holders — while 19 trimmed existing stakes and 24 added.

The largest buyer was Fidelity Investments, adding an estimated $4.03M. The largest seller was HealthCor Management, exiting entirely with an estimated $7.57M sold.

  • 62 institutional investors held Derma Sciences (DSCI) as of Q2 2015, down from 66 in Q1 2015.
  • Funds reported $174M of Derma Sciences stock for Q2 2015, down 4.5% quarter-over-quarter.
  • 14 funds opened new Derma Sciences positions in Q2 2015 and 18 closed out, a net change of -4 holders.
  • The largest Derma Sciences buyer in Q2 2015 was Fidelity Investments, an estimated $4.03M added.
  • The largest Derma Sciences seller in Q2 2015 was HealthCor Management, an estimated $7.57M sold.

Based on aggregated 13F filings for Q2 2015.